Beacon Biomedical Inc. — Form D/A
Beacon Biomedical Inc. of PHOENIX, AZ, a company, filed a Form D amendment with the SEC on 2021-09-20. The offering totals $1.6M, of which $523K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-20
- Form: D/A
- Accession: 0001677022-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $523K
- Remaining: $1.1M
- Minimum investment: $25K
- Investors: 17
- Date of first sale: 2018-03-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-308353
Issuer
- Name: Beacon Biomedical Inc.
- CIK: 0001677022
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 275 N. GATEWAY DRIVE, PHOENIX, AZ, 85034
- Phone: 480 757-9037
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Dirk F Beth | Director | PHOENIX, AZ |
| Andrew F Lombard | Director | PHOENIX, AZ |
| Donald F Weber | Director | PHOENIX, AZ |
| Donald F Weber | Executive Officer | PHOENIX, AZ |
| Dirk F Beth | Executive Officer | PHOENIX, AZ |
| F. Randall F Grimes | Director | PHOENIX, AZ |
| F. Randall F Grimes | Executive Officer | PHOENIX, AZ |
Other filings by this issuer (4)
More